5^th International Conference on Rare Diseases and Orphan Drugs

AI in Rare Disease Research: Artificial intelligence (AI) is increasingly being explored as a tool for identifying disease patterns, interpreting complex medical data, and supporting earlier diagnosis. In rare disease research, AI can help researchers analyse genetic information, medical images, clinical records, and patient symptoms to identify possible disease associations. This session covers machine learning, predictive modelling, computational diagnosis, and the responsible use of AI in rare disease research and clinical decision-making.

Orphan Drug Discovery: Orphan drug discovery focuses on identifying and developing medicines for conditions that affect relatively small patient populations and may receive limited attention during conventional drug development. Research in this area includes target identification, molecular screening, drug repurposing, preclinical testing, and the development of new therapeutic compounds. This session examines scientific innovations, development challenges, regulatory considerations, and approaches to making treatments more accessible to patients with rare diseases.

Clinical Case Reports and Case Studies: Clinical case reports describe individual patients or small groups whose medical conditions provide valuable insights into disease presentation, diagnosis, treatment, or progression. They are particularly important in rare diseases because clinicians may encounter only a few patients with a specific condition during their careers. This session highlights unusual clinical findings, diagnostic difficulties, treatment responses, newly recognised disease manifestations, and observations that may contribute to future research.

Rare Genetics, Genomics and Diagnosis: Rare diseases are associated with genetic variations that affect how cells, tissues, or organs develop and function. Genetics examines individual genes and their inheritance, while genomics investigates the broader genetic information of an individual or organism. This session explores genetic testing, genome sequencing, variant interpretation, inherited disorders, molecular diagnosis, and emerging methods for identifying the underlying causes of previously unexplained conditions.

Clinical Trials in Rare Diseases: Clinical trials evaluate the safety, effectiveness, and potential risks of new medicines, medical interventions, and treatment strategies. Conducting trials for rare diseases can be challenging because eligible patients may be geographically dispersed, patient populations may be small, and disease progression may be difficult to predict. This session addresses innovative trial designs, patient recruitment, outcome measurements, real-world evidence, ethical considerations, and approaches to generating reliable clinical evidence for rare disease treatments.

Rare Cancer Research and Oncology: Rare cancers are malignant diseases that occur infrequently compared with more common cancer types, including certain uncommon tumours and specific cancer subtypes. Their limited patient populations can make diagnosis, clinical research, and treatment development particularly challenging. This session explores tumour biology, molecular profiling, targeted therapies, precision oncology, emerging diagnostic methods, and research strategies for improving outcomes in patients with uncommon cancers.

Rare Disease Epidemiology and Public Health: Epidemiology examines the distribution, frequency, determinants, and outcomes of diseases within populations. In rare diseases, epidemiological research helps identify affected communities, estimate disease prevalence and incidence, recognise regional differences, and understand barriers to diagnosis and care. This session focuses on population-based research, disease registries, public health surveillance, health inequalities, access to specialised services, and policies designed to improve recognition and management of rare conditions.

Rare Hematological Disorders: Rare hematological disorders affect the blood, bone marrow, lymphatic system, or the processes responsible for producing and maintaining healthy blood cells. Examples include uncommon inherited blood disorders, rare coagulation deficiencies, unusual marrow failure syndromes, and certain uncommon blood cancers. This session covers disease mechanisms, laboratory diagnosis, genetic factors, transfusion practices, emerging treatments, and advances in managing complex blood-related conditions.

Rare Gynecology: Rare gynecological and reproductive disorders involve uncommon conditions affecting the female reproductive organs, hormonal regulation, fertility, or reproductive development. These conditions may include unusual congenital reproductive tract abnormalities, rare ovarian disorders, uncommon reproductive tumours, and specific disorders associated with reproductive function. This session examines diagnostic approaches, reproductive health challenges, fertility preservation, hormonal management, and developments in personalised care for patients with uncommon reproductive conditions.

Rare Infectious Diseases and Medical Microbiology: Rare infectious diseases are infections that occur infrequently within a particular population or geographical setting, although their frequency may vary significantly across regions. Medical microbiology investigates the microorganisms responsible for infections, including bacteria, viruses, fungi, and parasites, along with their interactions with the human body. This session explores uncommon infections, unusual microbial behaviour, host susceptibility, laboratory identification, antimicrobial resistance, emerging pathogens, and specialised diagnostic approaches.

Rare Otorhinolaryngological Disorders: Otorhinolaryngology focuses on diseases of the ear, nose, throat, and related structures of the head and neck. Rare disorders in this field may involve unusual hearing abnormalities, uncommon vestibular conditions, congenital airway differences, rare sinonasal diseases, or specialised head and neck disorders. This session discusses clinical recognition, hearing and balance assessment, advanced imaging, molecular diagnosis, surgical management, and innovative approaches to treating uncommon ear, nose, and throat conditions.

Rare Psychiatric Disorders and Mental Health: Rare psychiatric disorders are uncommon mental health conditions or distinctive clinical syndromes that may present with complex symptoms, atypical progression, or specific biological associations. Some rare genetic, metabolic, or neurological diseases can also produce psychiatric or behavioral symptoms that complicate diagnosis. This session examines clinical assessment, neurobiological mechanisms, psychiatric manifestations of rare diseases, multidisciplinary care, treatment challenges, and strategies for supporting patients and their families.

Rare Dental and Oral Disorders: Rare dental and oral disorders affect the teeth, gums, oral mucosa, salivary glands, jaw, or the development of oral structures. They may arise from inherited genetic conditions, developmental abnormalities, immune-related diseases, or uncommon pathological processes. This session explores oral manifestations of systemic rare diseases, specialised dental diagnosis, craniofacial abnormalities, preventive care, restorative approaches, and the role of dental professionals in recognising conditions that may otherwise remain undiagnosed.

Rare Neurology and Neuroscience: Rare neurological disorders affect the brain, spinal cord, peripheral nerves, or the neuromuscular system. They may cause difficulties with movement, coordination, cognition, sensation, communication, or other essential neurological functions. This session focuses on neurogenetics, disease mechanisms, neurological imaging, biomarkers, neurodegenerative conditions, neuromuscular disorders, and emerging treatments intended to improve neurological function and quality of life.

Rare Pediatric and Neonatal Disorders: Rare pediatric and neonatal disorders affect infants, children, or adolescents and may become apparent before birth, shortly after delivery, or during childhood development. Some conditions are inherited, while others involve developmental abnormalities, metabolic disturbances, immune dysfunction, or other biological mechanisms. This session addresses early recognition, newborn screening, paediatric diagnosis, congenital disorders, neonatal complications, specialised treatment, and long-term care designed around the developmental needs of young patients

Rare Dermatological and Skin Disorders: Rare dermatological disorders are uncommon conditions affecting the skin, hair, nails, or associated structures. They may result from genetic abnormalities, immune dysfunction, metabolic disturbances, or unusual inflammatory processes, with some conditions also affecting internal organs. This session explores clinical dermatology, molecular diagnosis, inherited skin diseases, rare blistering disorders, diagnostic imaging, targeted treatments, and approaches to improving skin health and patient quality of life.

Rare Obstetric Disorders: Rare obstetric disorders involve uncommon medical conditions that affect pregnancy, maternal health, fetal development, or the interaction between maternal and fetal physiology. Examples may include rare placental abnormalities, unusual pregnancy-associated complications, and uncommon inherited conditions identified during prenatal assessment. This session examines prenatal diagnosis, maternal–fetal monitoring, genetic counselling, specialised pregnancy management, multidisciplinary decision-making, and strategies for improving outcomes for both mothers and babies.

Rare Endocrine and Hormonal Disorders: Rare endocrine disorders affect hormone-producing glands and the biological processes that regulate growth, metabolism, reproduction, stress responses, and other essential functions. These conditions may involve uncommon pituitary, adrenal, thyroid, parathyroid, or pancreatic disorders, as well as rare disturbances in hormone production or action. This session covers endocrine evaluation, hormonal testing, molecular mechanisms, metabolic complications, individualised treatment, and emerging approaches to managing uncommon hormonal conditions.

Rare Musculoskeletal Disorders: Rare bone and musculoskeletal disorders affect the development, structure, strength, or function of bones, joints, muscles, connective tissues, and related structures. Examples include uncommon skeletal dysplasias, inherited connective tissue disorders, rare muscle diseases, and certain metabolic bone conditions. This session explores genetic and molecular mechanisms, skeletal imaging, disease progression, mobility challenges, rehabilitation, orthopaedic interventions, and emerging treatments aimed at preserving physical function.

Gene Therapy and Regenerative Medicine: Gene therapy aims to treat or prevent disease by modifying genetic material or introducing genetic instructions into cells, while regenerative medicine seeks to repair, replace, or restore damaged cells, tissues, or biological functions. These approaches are particularly relevant to selected rare diseases in which a defined genetic defect or loss of cellular function contributes to the condition. This session examines gene delivery systems, genome editing, cell-based therapies, tissue engineering, safety assessment, clinical translation, and the scientific challenges involved in developing advanced treatments.

Rare Cardiovascular and Heart Diseases: Rare cardiovascular disorders affect the heart, blood vessels, or the electrical and structural systems responsible for normal circulation. They may include inherited cardiomyopathies, uncommon congenital heart defects, rare vascular disorders, and specific genetic conditions associated with abnormal heart rhythms. This session covers cardiovascular genetics, diagnostic imaging, electrocardiography, disease monitoring, personalised treatment, risk assessment, and advances in the management of uncommon heart and vascular conditions.

Rare Immunological Disorders and Vaccine Research: Rare immunological disorders involve uncommon abnormalities in the immune system that may impair the body's ability to fight infections, cause excessive inflammation, or lead to inappropriate immune responses. These conditions include selected primary immunodeficiencies, rare autoinflammatory diseases, and unusual immune dysregulation syndromes. This session explores immune mechanisms, diagnostic biomarkers, immunomodulatory treatments, vaccine responses in specialised patient groups, and research into improving infection prevention and immune protection for individuals with rare immune disorders.